An exploratory sensitivity analysis in biologic-naïve patients yielded an adjusted HR of 0.27 (95% CI: 0.05–1.30), which did not reach statistical significance ( p = 0.102).
← all excerpts
Comparative risk of <i>Clostridioides difficile</i> infection in patients with Crohn's disease receiving ustekinumab versus anti-TNF therapy: a retrospective cohort study.
1
0.1020
0.1020